Publications by authors named "Leila Lefevre"

Objectives: The anticipated increase in international tourist flows and the first locally acquired dengue cases in the Paris region in October 2023 have raised concerns about potential arbovirus outbreaks during the 2024 Olympics. Unlike previous mass sporting events at risk of arbovirus outbreaks, Paris is a nonendemic arbovirus area, requiring a unique investigation.

Methods: Therefore, we analyzed factors conducive to possible arbovirus epidemics in temperate regions: vector distribution in the Paris area, seasonal global arboviral disease patterns, projected visitor demographics, and international flight bookings.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the effectiveness and safety of ChatGPT-4 in managing patients with positive blood cultures in a hospital setting over four weeks.
  • ChatGPT-4 provided comprehensive management plans that matched the recommendations of infectious disease consultants in about 59% of cases, but had limitations in diagnostic accuracy and appropriate treatment options.
  • The research concluded that relying solely on ChatGPT-4 for medical advice can be risky, particularly for severe infections, highlighting the need for expert oversight.
View Article and Find Full Text PDF

Background/aim: Olaparib was approved in 2014 by the European Medicines Agency (EMA) as maintenance treatment for patients with breast cancer gene (BRCA)-mutated platinum-sensitive relapsed high-grade epithelial ovarian cancer (EOC) following the results of the Study 19. We present the results of a national real-world study on the effectiveness of olaparib in relapsed BRCA-mutated EOC patients.

Patients And Methods: Patients with EOC, peritoneal, and/or fallopian-tube cancer treated with olaparib in a French Center between May 2014 and March 2017 were included.

View Article and Find Full Text PDF

Background: Colon adenocarcinoma mainly occurs in older patients. Oxaliplatin-based adjuvant chemotherapy improved disease-free survival after stage III colon cancer resection, but this improvement was not demonstrated in older patients.

Methods: The purpose of ADAGE-PRODIGE 34, randomized open phase III trial is to compare in patients over 70 years oxaliplatin plus fluoropyrimidine with fluoropyrimidine alone in fit patients (Group 1) and fluoropyrimidine with observation in frail patients (Group 2) after resection of stage III colon adenocarcinoma.

View Article and Find Full Text PDF

Low-grade serous carcinoma represents a minority of serous carcinoma. Although they have better prognosis than high-grade serous carcinoma, they respond poorly to chemotherapy. Thus, it appears necessary to find other treatments such as targeted therapies.

View Article and Find Full Text PDF

Background: The purpose of the present study was to assess the prognostic impact of positive surgical margins (R1) after liver resection (LR) of colorectal liver metastases (CRLM) in the era of modern chemotherapy regimens. R1 resection is a negative prognostic factor after LR of CRLM. The significance of R1 margins in the era of effective chemotherapy is unknown.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Leila Lefevre"

  • - Leila Lefevre's recent research primarily focuses on the intersection of infectious diseases and public health, with current investigations into the implications of major events, such as the 2024 Paris Olympic Games, on arboviral disease outbreaks and healthcare innovations like AI chatbot applications in managing bloodstream infections.
  • - The research includes a prospective cohort study evaluating the effectiveness and safety of ChatGPT-4 in the context of infectious diseases, highlighting the potential and challenges of integrating AI into clinical practices.
  • - Additionally, Lefevre is involved in studies addressing the diagnosis of fungal infections in endophthalmitis, real-world applications of cancer treatments like olaparib for BRCA-mutated ovarian cancer, and analyzing the tolerance of chemotherapy in older patients with stage III colon cancer, showcasing a diverse approach towards improving patient care across various medical conditions.